Marlen Metzner

2.1k total citations
15 papers, 123 citations indexed

About

Marlen Metzner is a scholar working on Hematology, Molecular Biology and Immunology. According to data from OpenAlex, Marlen Metzner has authored 15 papers receiving a total of 123 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Hematology, 5 papers in Molecular Biology and 4 papers in Immunology. Recurrent topics in Marlen Metzner's work include Acute Myeloid Leukemia Research (9 papers), Cancer Genomics and Diagnostics (4 papers) and Single-cell and spatial transcriptomics (2 papers). Marlen Metzner is often cited by papers focused on Acute Myeloid Leukemia Research (9 papers), Cancer Genomics and Diagnostics (4 papers) and Single-cell and spatial transcriptomics (2 papers). Marlen Metzner collaborates with scholars based in United Kingdom, United States and Germany. Marlen Metzner's co-authors include Paresh Vyas, Richard Welch, P M Wilkinson, G.R. Morgenstern, M. Decatris, Sally Jeffries, Claudia Walter, Paul Ferguson, Keith Wheatley and Charles Craddock and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Cell stem cell.

In The Last Decade

Marlen Metzner

15 papers receiving 122 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marlen Metzner United Kingdom 5 87 29 26 21 20 15 123
Elisabet Björklund Sweden 6 88 1.0× 30 1.0× 15 0.6× 7 0.3× 36 1.8× 6 153
Matt Rosales United States 6 122 1.4× 63 2.2× 13 0.5× 8 0.4× 38 1.9× 14 150
Yoshiaki Usui Japan 7 51 0.6× 38 1.3× 13 0.5× 12 0.6× 20 1.0× 22 119
Fernando Roncolato Australia 8 109 1.3× 57 2.0× 7 0.3× 5 0.2× 48 2.4× 17 183
Salvatore Serravalle Italy 8 83 1.0× 120 4.1× 14 0.5× 11 0.5× 9 0.5× 15 198
Pallavi Galera United States 6 53 0.6× 20 0.7× 8 0.3× 9 0.4× 33 1.6× 13 153
María C. Viguria Spain 4 114 1.3× 19 0.7× 9 0.3× 5 0.2× 25 1.3× 14 151
Himanshu Chheda Finland 4 47 0.5× 33 1.1× 8 0.3× 3 0.1× 27 1.4× 4 124
Sander Lambo Germany 4 14 0.2× 70 2.4× 18 0.7× 31 1.5× 36 1.8× 6 115
Jeeyeon Baik United States 6 61 0.7× 33 1.1× 5 0.2× 13 0.6× 31 1.6× 18 151

Countries citing papers authored by Marlen Metzner

Since Specialization
Citations

This map shows the geographic impact of Marlen Metzner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marlen Metzner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marlen Metzner more than expected).

Fields of papers citing papers by Marlen Metzner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marlen Metzner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marlen Metzner. The network helps show where Marlen Metzner may publish in the future.

Co-authorship network of co-authors of Marlen Metzner

This figure shows the co-authorship network connecting the top 25 collaborators of Marlen Metzner. A scholar is included among the top collaborators of Marlen Metzner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marlen Metzner. Marlen Metzner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Elliott, Natalina, Neha Bhatnagar, Gemma Buck, et al.. (2025). Clinical significance of preleukemic somatic GATA1 mutations in children with Down syndrome. Blood. 146(13). 1561–1574. 1 indexed citations
2.
Johnson, Lisa D., Marlen Metzner, François G. Kavelaars, et al.. (2024). Mutational Landscape and Depth of Response in Patients with Acute Myeloid Leukemia (AML) Treated with Magrolimab in Combination with Venetoclax and Azacitidine Compared to Placebo. Blood. 144(Supplement 1). 2914–2914. 1 indexed citations
3.
Gafencu, Grigore, Bilyana Stoilova, Mario Buono, et al.. (2024). Hematopoietic stem cell heterogeneity and age-associated platelet bias are evolutionarily conserved. Science Immunology. 9(98). eadk3469–eadk3469. 10 indexed citations
4.
Turkalj, Sven, Niels Asger Jakobsen, Marlen Metzner, et al.. (2023). GTAC enables parallel genotyping of multiple genomic loci with chromatin accessibility profiling in single cells. Cell stem cell. 30(5). 722–740.e11. 7 indexed citations
5.
Sternberg, Alexander, Rebecca H. Boucher, Manoj Raghavan, et al.. (2022). Phase Ib study of eltrombopag and azacitidine in patients with high‐risk myelodysplastic syndromes and related disorders (the ELASTIC study). British Journal of Haematology. 199(2). 222–229. 2 indexed citations
6.
Metzner, Marlen, Batchimeg Usukhbayar, Aimee Jackson, et al.. (2022). Heterogeneous genetic and non‐genetic mechanisms contribute to response and resistance to azacitidine monotherapy. SHILAP Revista de lepidopterología. 3(3). 794–803. 2 indexed citations
7.
Sweeney, Connor, Marlen Metzner, Batchimeg Usukhbayar, et al.. (2022). Graft Versus Leukaemia (GvL): Identification & Characterisation of Alloreactive Antigens and Cognate T Cell Responses in Acute Myeloid Leukemia. Blood. 140(Supplement 1). 1576–1578. 2 indexed citations
8.
Jakobsen, Niels Asger, Sven Turkalj, Bilyana Stoilova, et al.. (2022). Single-Cell Analysis of Human Clonal Hematopoiesis Identifies Distinct Impact of DNMT3A and TET2 mutations on Hematopoietic Differentiation. Blood. 140(Supplement 1). 2227–2228. 3 indexed citations
9.
Siejka-Zielińska, Paulina, Marlen Metzner, Batchimeg Usukhbayar, et al.. (2022). Dysregulation of Stem-Progenitor and Differentiation Programmes through Modulation of Bivalent Chromatin Drives Leukemogenesis in Mutant IDH2 Acute Myeloid Leukaemia. Blood. 140(Supplement 1). 8698–8699. 1 indexed citations
10.
Loke, Justin, Marlen Metzner, Rebecca H. Boucher, et al.. (2021). Combination romidepsin and azacitidine therapy is well tolerated and clinically active in adults with high‐risk acute myeloid leukaemia ineligible for intensive chemotherapy. British Journal of Haematology. 196(2). 368–373. 3 indexed citations
11.
Roos‐Weil, Damien, Brian Giacopelli, Marine Armand, et al.. (2020). Identification of two DNA methylation subtypes of Waldenström's macroglobulinemia with plasma and memory B cell features. Blood. 136(5). 585–595. 6 indexed citations
12.
Craddock, Charles, Lynn Quek, Aimee E. Houlton, et al.. (2017). MOLECULAR PREDICTORS OF RESPONSE TO AZACITIDINE THERAPY: THE RESULTS OF THE UK TRIALS ACCELERATION PROGRAMME RAVVA STUDY. Haematologica. 102. 323–323. 4 indexed citations
13.
Quek, Lynn, Paul Ferguson, Marlen Metzner, et al.. (2016). Mutational analysis of disease relapse in patients allografted for acute myeloid leukemia. Blood Advances. 1(3). 193–204. 49 indexed citations
14.
15.
Metzner, Marlen, et al.. (1999). Efficacy of an Immune Modulator in Enzootic Pneumonia of Dairy Calves. Journal of Veterinary Medicine Series A. 46(5). 293–299. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elisabet Björklund Breakdown of academic impact, for papers by Matt Rosales Breakdown of academic impact, for papers by Yoshiaki Usui Breakdown of academic impact, for papers by Fernando Roncolato Breakdown of academic impact, for papers by Salvatore Serravalle Breakdown of academic impact, for papers by Pallavi Galera Breakdown of academic impact, for papers by María C. Viguria Breakdown of academic impact, for papers by Himanshu Chheda Breakdown of academic impact, for papers by Sander Lambo Breakdown of academic impact, for papers by Jeeyeon Baik
Rankless by CCL
2026